{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifkt6kqmbj4xjfer5sfnwo3kyxcy6qlbtmwlh4faorazi7p2zjaoa",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfznddvf2ti2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih436yyahudxdjv5pg3g66vbg654fdntcc5ltwlil2zt7lntdv2ou"
    },
    "mimeType": "image/jpeg",
    "size": 436127
  },
  "path": "/news/2026-02-twenty-years-cancer-free-story.html",
  "publishedAt": "2026-03-01T16:00:03.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Immunology"
  ],
  "textContent": "Twenty years. That's how long Robert Oman has been cancer-free, thanks to a clinical trial offered at the University of Rochester's Wilmot Cancer Institute. And he isn't alone: 70% of patients in the trial who had advanced-stage follicular lymphoma survived at least 15 years after completing a standard treatment regimen of immunotherapy and a chemotherapy combination, known as CHOP.",
  "title": "Twenty years cancer-free: One man's story illustrates progress against follicular lymphoma"
}